Ken Griffin Haleon PLC Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$8.02 - $8.67 $1.47 Million - $1.59 Million	-183,300 Reduced 87.24%	26,800 $227,000
Q4 2023 Feb 14, 2024	BUY	$7.78 - $8.62 $73,910 - $81,889	9,500 Added 4.74%	210,100 $1.73 Million
Q3 2023 Nov 14, 2023	SELL	$7.85 - $8.94 $544,005 - $619,542	-69,300 Reduced 25.68%	200,600 $1.67 Million
Q2 2023 Aug 14, 2023	BUY	$8.04 - $9.0 $673,751 - $754,200	83,800 Added 45.03%	269,900 $2.26 Million
Q1 2023 May 15, 2023	SELL	$7.57 - $8.37 $538,227 - $595,107	-71,100 Reduced 27.64%	186,100 $1.51 Million

Q4 2022 Feb 14, 2023	BUY	$6.08 - $8.06 $742,976 - $984,932	122,200 Added 90.52%	257,200 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$5.63 - $7.49 $760,050 - $1.01 Million	135,000 New	135,000 $822,000

636

424M

82K

27.3K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $38.1B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.